510(k) K262136

BIOFIRE SPOTFIRE Vaginitis (VG) Panel by Biofire Diagnostics, LLC — Product Code PQA

K262136 is an FDA 510(k) premarket notification submitted by Biofire Diagnostics, LLC for the device "BIOFIRE SPOTFIRE Vaginitis (VG) Panel". The FDA issued a decision of Substantially Equivalent on Oct 21, 2026. The device falls under product code PQA (Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System), a Class II device regulated under 21 CFR 866.3975. Biofire Diagnostics, LLC has 36 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Oct 21, 2026
Date Received
Jun 25, 2026
Clearance Type
Dual Track
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System
Device Class
Class II
Regulation Number
866.3975
Review Panel
MI
Submission Type
510(k)

A vaginitis and bacterial vaginosis nucleic acid detection system is a qualitative in vitro diagnostic device for the direct detection of nucleic acid sequences from microorganisms associated with vaginitis or bacterial vaginosis. The device is indicated for individuals with signs and symptoms of vaginitis or bacterial vaginosis and aids in the diagnosis of these vaginal infections.

Source: FDA 510(k) database entry for K262136. Report a data issue: hello@regdatalab.com.